日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations

对于伴有KIT基因9号外显子突变的胃肠道间质瘤患者,辅助伊马替尼治疗或观察的疗效评价

Napolitano, Andrea; Joensuu, Heikki; Rothschild, Sara; Evans, Denisse; Heinrich, Michael C; Sutton, Thomas L; Mayo, Skye C; Boye, Kjetil; Falkenhorst, Johanna; Le Cesne, Axel; Hohenberger, Peter; Rutkowski, Piotr; van Houdt, Winan J; Steeghs, Neeltje; Gelderblom, Hans; Desar, Ingrid M E; Pantaleo, Maria A; Nishida, Toshiro; Reichardt, Peter; Blay, Jean-Yves; Somaiah, Neeta; Haddad, Elise F Nassif; Grignani, Giovanni; Baldi, Giacomo G; Steigen, Sonja E; Braconi, Chiara; Nilsson, Bengt; Singh, Arun S; Fumagalli, Elena; Cananzi, Ferdinando C M; Italiano, Antoine; Ceruso, Mariella Spalato; Brunello, Antonella; Magnússon, Magnús K; Jonasson, Jon G; Marquina, Gloria; Hindi, Nadia; Cirilli, Claudia; Federico, Massimo; Fausti, Valentina; Bordoni, Andrea; Sufliarsky, Jozef; Mazzocca, Alessandro; Martin-Broto, Javier; Gronchi, Alessandro; Trent, Jonathan C; Casali, Paolo G; Bauer, Sebastian; Jones, Robin L; Vincenzi, Bruno

Quality of Life and Experiences of Patients with Gastrointestinal Stromal Tumors (GIST) on Imatinib Treatment

接受伊马替尼治疗的胃肠道间质瘤(GIST)患者的生活质量和体验

Westerdijk, Kim; Steeghs, Neeltje; van der Graaf, Winette T A; Groen, Joost S; van Erp, Nielka P; Hermens, Rosella P M G; Desar, Ingrid M E

Health-related quality of life in patients with advanced soft tissue sarcoma receiving first-line palliative chemotherapy (HOLISTIC): longitudinal results from a prospective, observational cohort study

接受一线姑息化疗的晚期软组织肉瘤患者的健康相关生活质量(HOLISTIC):一项前瞻性观察性队列研究的纵向结果

Roets, Evelyne; Younger, Eugenie; Jones, Robin L; Hollander, Dide den; Azarang, Leyla; Desar, Ingrid M E; Young, Robin J; Oosten, Astrid W; de Haan, Jacco J; Gelderblom, Hans; Steeghs, Neeltje; Husson, Olga; van der Graaf, Winette T A

Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses

Cemiplimab治疗局部晚期或转移性继发性血管肉瘤(CEMangio):一项II期临床试验和生物标志物分析

Stefan G van Ravensteijn,Jacco J de Haan,Hans Gelderblom,Maikel J L Nederkoorn,Melissa H S Hillebrandt-Roeffen,Mark A J Gorris,Tessa J J de Bitter,Annemarie Boleij,Alem Gusinac,Thomas H A Ederveen,Uta E Flucke,Johannes J Bonenkamp,Frank M Speetjens,Suzanne E J Kaal,Minke Smits,Kalijn F Bol,Carla M L van Herpen,Yvonne M H Versleijen-Jonkers,Ingrid M E Desar

Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses

Cemiplimab治疗局部晚期或转移性继发性血管肉瘤(CEMangio):一项II期临床试验和生物标志物分析

Stefan G van Ravensteijn ,Jacco J de Haan ,Hans Gelderblom ,Maikel J L Nederkoorn ,Melissa H S Hillebrandt-Roeffen ,Mark A J Gorris ,Tessa J J de Bitter ,Annemarie Boleij ,Alem Gusinac ,Thomas H A Ederveen ,Uta E Flucke ,Johannes J Bonenkamp ,Frank M Speetjens ,Suzanne E J Kaal ,Minke Smits ,Kalijn F Bol ,Carla M L van Herpen ,Yvonne M H Versleijen-Jonkers ,Ingrid M E Desar

Impact of Mutation Profile on Outcomes of Neoadjuvant Therapy in GIST

突变谱对胃肠道间质瘤新辅助治疗疗效的影响

Mohammadi, Mahmoud; Roets, Evelyne; Bleckman, Roos F; Oosten, Astrid W; Grunhagen, Dirk; Desar, Ingrid M E; Bonenkamp, Han; Reyners, Anna K L; van Etten, Boudewijn; Hartgrink, Henk; Fiocco, Marta; Schrage, Yvonne; Steeghs, Neeltje; Gelderblom, Hans

Double burden: financial toxicity in patients with advanced soft tissue sarcoma at the start of first-line palliative chemotherapy: baseline data from the HOLISTIC study

双重负担:晚期软组织肉瘤患者在接受一线姑息化疗之初面临的经济压力:来自 HOLISTIC 研究的基线数据

Roets, E; Younger, E; Jones, R L; Hollander, D den; Desar, I M E; Young, R J; Oosten, A W; de Haan, J J; Gelderblom, H; Steeghs, N; van der Graaf, W T A; Husson, O

Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs: The ROAD Study

通过重新分配未使用的口服抗癌药物来节省成本并减少浪费:ROAD 研究

Smale, Elisabeth M; van den Bemt, Bart J F; Heerdink, Eibert R; Desar, Ingrid M E; Egberts, Toine C G; Bekker, Charlotte L

Sunitinib for the treatment of metastatic gastrointestinal stromal tumors: the effect of TDM-guided dose optimization on clinical outcomes

舒尼替尼治疗转移性胃肠道间质瘤:治疗药物监测指导的剂量优化对临床疗效的影响

Giraud, E L; Westerdijk, K; van der Kleij, M B A; Guchelaar, N A D; Meertens, M; Bleckman, R F; Rieborn, A; Mohammadi, M; Roets, E; Mathijssen, R H J; Huitema, A D R; Koolen, S L W; Gelderblom, H; Moes, D J A R; Reyners, A K L; Touw, D J; Keizer-Heldens, P; Oosten, A W; van der Graaf, W T A; Steeghs, N; van Erp, N P; Desar, I M E

Levels of circulating tumor DNA correlate with tumor volume in gastro-intestinal stromal tumors: an exploratory long-term follow-up study

循环肿瘤DNA水平与胃肠道间质瘤肿瘤体积相关:一项探索性长期随访研究

Bleckman, Roos F; Haag, Charlotte M S C; Rifaela, Naomi; Beukema, Gerrieke; Mathijssen, Ron H J; Steeghs, Neeltje; Gelderblom, Hans; Desar, Ingrid M E; Cleven, Arjen; Ter Elst, Arja; Schuuring, Ed; Reyners, Anna K L